New Vaccine Post-Introduction Evaluation - libdoc.who.int - World ...

More documents

Recommendations

Info

Abbreviation BACKGROUND INFORMATION GEN 1. Date new vaccine introduced at national/regional/ district level GEN GEN CENT CENT Note: If interviewing region or district, put date for appropriate area. 2. Was the new vaccine introduced nationwide or was it a phased introduction? 3. What is the population of children less than one year of age in this country/region/ district? Note: If not available for
Abbreviation ROTA GEN 11. Is there a required minimum interval between doses? Note: Correct answer is 4 weeks. Central/Regional/District Questionnaire Yes No Don’t know If yes, length of interval ____________________________________ PRE-IMPLEMENTATION PLANNING AND VACCINE INTRODUCTION PROCESS 12. Do you have a central/regional/district new vaccine introduction plan or timeline for introduction activities? Note: For example, if someone from the district only has a national plan, just check national plan. If they have a national and a district plan check both. Yes national plan/timeline Yes, regional plan/timeline Yes, district plan/timeline Interviewer please ask for a copy at time of interview. Review later to ensure essential components are included. CENT GEN Ask only if response to question 12 was “yes” 13. Did you receive support or use guidelines to develop your introduction plan/timeline? TRAINING 14. Please describe staff training for the new vaccine introduction, if any. No. If no, why not? ____________________________________ Yes. If yes, specify support? ____________________________________ No. If no, why not? ____________________________________ Don’t know ____________________________________ Target audience for the training Doctors Nurses Health-care workers Other (specify) GEN 15. How were the trainings financed? Type of training Cascade Region-by-region Other (specify) Was training conducted before vaccine introduction Yes No If yes, how long before __________________ Was training conducted after vaccine introduction Yes No If yes, how long after _ __________________ How long was the training? ___________ Who conducted the training at each level? Regions:_ ____________________________ District:______________________________ Health facilities:________________________ Other comments on training:______________ 26 New Vaccine Post-Introduction Evaluation (PIE) Tool
Page 1 and 2: WHO/IVB/10.03 ORIGINAL: ENGLISH New
Page 3 and 4: The Department of Immunization, Vac
Page 5 and 6: 5. Appendices......................
Page 7 and 8: Acknowledgements This Post-Introduc
Page 9 and 10: viii
Page 11 and 12: 1.3 What is a PIE? A PIE is a post-
Page 13 and 14: Table 2: Example of data and docume
Page 15 and 16: When in the field, teams should ide
Page 17 and 18: 2. Evaluation areas Data are collec
Page 19 and 20: Coverage The primary indicator of v
Page 21 and 22: 2.3 Cold-chain management Some vacc
Page 23 and 24: 2.5 Monitoring and supervision A fi
Page 25 and 26: 2.8 Vaccine wastage Wastage, partic
Page 27 and 28: 3. Data synthesis and reporting A l
Page 29 and 30: 4. Reference documents / websites
Page 31 and 32: Appendix 2: Questionnaires Layout a
Page 33: Appendix 2.1: Questionnaire — cen
Page 37 and 38: Abbreviation CENT/REG GEN GEN GEN G
Page 39 and 40: Abbreviation GEN GEN GEN PENTA PENT
Page 41 and 42: Abbreviation CENT CENT CENT C&R SUS
Page 43 and 44: Abbreviation GEN GEN GEN For vaccin
Page 45 and 46: Abbreviation GEN GEN GEN 1. Were yo
Page 47 and 48: Abbreviation GEN GEN 15. Have immun
Page 49 and 50: Abbreviation GEN GEN WASTE MANAGEME
Page 51 and 52: Abbreviation ROTA ROTA PENTA GEN GE
Page 53 and 54: Abbreviation GEN 64. Are appropriat
Page 55 and 56: Appendix 2.3: Questionnaire — mot
Page 57 and 58: Appendix 4: Summary spreadsheet Sum
Page 59 and 60: Level Question Central Regional Reg
Page 67 and 68: Appendix 5: Summary spreadsheet Sum
Page 69 and 70: Advocacy, Communication and Accepta
Page 71 and 72: Appendix 6: Common problems and sol
Page 73 and 74: Scenario Over- or under-stock of va
Page 75 and 76: 66 New Vaccine Post-Introduction Ev

New Vaccine Post-Introduction Evaluation - libdoc.who.int - World ...

Create successful ePaper yourself

Delete template?

Save as template?